5-cyclopropyl-3-methyl-N-[3-(1-methylpyrazol-4-yl)-1,2,4-thiadiazol-5-yl]-1,2-oxazole-4-carboxamide
C14H14N6O2S — CID 154771104
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-cyclopropyl-3-methyl-N-[3-(1-methylpyrazol-4-yl)-1,2,4-thiadiazol-5-yl]-1,2-oxazole-4-carboxamide
5-cyclopropyl-3-methyl-N-[3-(1-methylpyrazol-4-yl)-1,2,4-thiadiazol-5-yl]-1,2-oxazole-4-carboxamide (PubChem CID 154771104) has the molecular formula C14H14N6O2S and a molecular weight of 330.37 g/mol. Its IUPAC name is 5-cyclopropyl-3-methyl-N-[3-(1-methylpyrazol-4-yl)-1,2,4-thiadiazol-5-yl]-1,2-oxazole-4-carboxamide.
Molecular Properties
| Compound Name | 5-cyclopropyl-3-methyl-N-[3-(1-methylpyrazol-4-yl)-1,2,4-thiadiazol-5-yl]-1,2-oxazole-4-carboxamide |
|---|---|
| PubChem CID | 154771104 |
| Molecular Formula | C14H14N6O2S |
| Molecular Weight | 330.37 g/mol |
| Exact Mass | 330.09 |
| IUPAC Name | 5-cyclopropyl-3-methyl-N-[3-(1-methylpyrazol-4-yl)-1,2,4-thiadiazol-5-yl]-1,2-oxazole-4-carboxamide |
| SMILES | Cc1noc(C2CC2)c1C(=O)Nc1nc(-c2cnn(C)c2)ns1 |
| InChI | InChI=1S/C14H14N6O2S/c1-7-10(11(22-18-7)8-3-4-8)13(21)17-14-16-12(19-23-14)9-5-15-20(2)6-9/h5-6,8H,3-4H2,1-2H3,(H,16,17,19,21) |
| InChIKey | ZCESEHCBSMESJL-UHFFFAOYSA-N |
| XLogP | 2.36 |
| TPSA | 98.73 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 330.37 |
| LogP ≤ 5 | 2.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154771104 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.